Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ivan Pasic

Showing results (11-20 of 91) with videos related to

Pageof 10
Sort By:
Current Oncology (Toronto, Ont.)|January 24, 2025
Matched Unrelated Donor Hematopoietic Cell Transplantation: Increased Usage and Improvements in Clinical Outcomes in CanadaMatthew D Seftel, Grace Musto, David Allan, et al.
Human Molecular Genetics|November 22, 2002
The Bloom syndrome helicase BLM interacts with TRF2 in ALT cells and promotes telomeric DNA synthesisDimitrios J Stavropoulos, Paul S Bradshaw, Xiaobin Li, et al.
Cancer Research|January 6, 2010
Recurrent focal copy-number changes and loss of heterozygosity implicate two noncoding RNAs and one tumor suppressor gene at chromosome 3q13.31 in osteosarcomaIvan Pasic, Adam Shlien, Adam D Durbin, et al.
Hematology/Oncology and Stem Cell Therapy|March 8, 2021
Subcutaneous immunoglobulin in allogeneic hematopoietic cell transplant patients: A prospective study of feasibility, safety, and healthcare resource useIvan Pasic, Wael Alanazi, George Dranitsaris, et al.
Clinical Kidney Journal|July 27, 2022
Chronic kidney disease, survival and graft-versus-host-disease-free/relapse-free survival in recipients of allogeneic hematopoietic stem cell transplantKaryne Pelletier, Gabrielle Côté, Kayla Madsen, et al.
Clinical Chemistry and Laboratory Medicine|January 19, 2023
Multiplex proteomics using proximity extension assay for the identification of protein biomarkers predictive of acute graft-vs.-host disease in allogeneic hematopoietic cell transplantationIvan Pasic, Annie H Ren, Ram Vasudevan Nampoothiri, et al.
Annals of Hematology|May 9, 2020
Post-transplant cyclophosphamide combined with anti-thymocyte globulin for graft-vs-host disease prophylaxis improves survival and lowers non-relapse mortality in older patients undergoing allogeneic hematopoietic cell transplantationIvan Pasic, Jeffrey H Lipton, Dennis D Kim, et al.
European Journal of Haematology|February 2, 2019
Influence of FLT3-ITD and NPM1 status on allogeneic hematopoietic cell transplant outcomes in patients with cytogenetically normal AMLIvan Pasic, Waleed Da'na, Wilson Lam, et al.
European Journal of Haematology|July 20, 2024
Letermovir as secondary prophylaxis of cytomegalovirus infection after allogeneic hematopoietic cell transplantation: A single center experienceNihar Desai, Ivan Pasic, Arjun D Law, et al.
Transplantation and Cellular Therapy|January 12, 2026
Clinical Impact of HHV-6B Reactivation on Engraftment and Outcomes Following Allogeneic Hematopoietic Stem Cell TransplantationSeyed M Hosseini-Moghaddam, Rochelle B Johnstone, Tony Mazzulli, et al.
Pageof 10

Showing results (11-20 of 91) with videos related to

Sort By:
Pageof 10
Current Oncology (Toronto, Ont.)|January 24, 2025
Matched Unrelated Donor Hematopoietic Cell Transplantation: Increased Usage and Improvements in Clinical Outcomes in CanadaMatthew D Seftel, Grace Musto, David Allan, et al.
Human Molecular Genetics|November 22, 2002
The Bloom syndrome helicase BLM interacts with TRF2 in ALT cells and promotes telomeric DNA synthesisDimitrios J Stavropoulos, Paul S Bradshaw, Xiaobin Li, et al.
Cancer Research|January 6, 2010
Recurrent focal copy-number changes and loss of heterozygosity implicate two noncoding RNAs and one tumor suppressor gene at chromosome 3q13.31 in osteosarcomaIvan Pasic, Adam Shlien, Adam D Durbin, et al.
Hematology/Oncology and Stem Cell Therapy|March 8, 2021
Subcutaneous immunoglobulin in allogeneic hematopoietic cell transplant patients: A prospective study of feasibility, safety, and healthcare resource useIvan Pasic, Wael Alanazi, George Dranitsaris, et al.
Clinical Kidney Journal|July 27, 2022
Chronic kidney disease, survival and graft-versus-host-disease-free/relapse-free survival in recipients of allogeneic hematopoietic stem cell transplantKaryne Pelletier, Gabrielle Côté, Kayla Madsen, et al.
Clinical Chemistry and Laboratory Medicine|January 19, 2023
Multiplex proteomics using proximity extension assay for the identification of protein biomarkers predictive of acute graft-vs.-host disease in allogeneic hematopoietic cell transplantationIvan Pasic, Annie H Ren, Ram Vasudevan Nampoothiri, et al.
Annals of Hematology|May 9, 2020
Post-transplant cyclophosphamide combined with anti-thymocyte globulin for graft-vs-host disease prophylaxis improves survival and lowers non-relapse mortality in older patients undergoing allogeneic hematopoietic cell transplantationIvan Pasic, Jeffrey H Lipton, Dennis D Kim, et al.
European Journal of Haematology|February 2, 2019
Influence of FLT3-ITD and NPM1 status on allogeneic hematopoietic cell transplant outcomes in patients with cytogenetically normal AMLIvan Pasic, Waleed Da'na, Wilson Lam, et al.
European Journal of Haematology|July 20, 2024
Letermovir as secondary prophylaxis of cytomegalovirus infection after allogeneic hematopoietic cell transplantation: A single center experienceNihar Desai, Ivan Pasic, Arjun D Law, et al.
Transplantation and Cellular Therapy|January 12, 2026
Clinical Impact of HHV-6B Reactivation on Engraftment and Outcomes Following Allogeneic Hematopoietic Stem Cell TransplantationSeyed M Hosseini-Moghaddam, Rochelle B Johnstone, Tony Mazzulli, et al.
Pageof 10